Aimmune Therapeutics (AIMT) Priced

Developing an oral immunotherapy to desensitize peanut allergies.

Health Care - Biotechnology

IPO Performance
Latest Trade $21.00 +0.73 (+3.6%)
First Day Return 50.6%
Return from IPO 26.7%
 
Aimmune Therapeutics IPO News more
  • .
IPO Data
IPO File Date 07/06/2015
Offer Price $16.00
Price Range $14.00 - $16.00
Offer Shares (mm) 10.0
Deal Size ($mm) 160
 
IPO Data
IPO Date 08/05/2015
Offer Price $16.00
Price Range $14.00 - $16.00
Offer Shares (mm) 10.0
Deal Size ($mm) $160
 
Underwriters
more
Business Overview
Developing an oral immunotherapy to desensitize peanut allergies.
Developing an oral immunotherapy to desensitize peanut allergies.
more
Company Data
Headquarters Brisbane, CA
Founded 2011
Employees 21
Website www.aimmune.com
 

Performance vs. IPO Index (IPOUSA)